179 related articles for article (PubMed ID: 16040601)
21. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
[TBL] [Abstract][Full Text] [Related]
22. Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation.
Johnson SL; Ranxhi B; Libohova K; Tsou WL; Todi SV
Elife; 2020 Sep; 9():. PubMed ID: 32955441
[TBL] [Abstract][Full Text] [Related]
23. Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23.
Blount JR; Tsou WL; Ristic G; Burr AA; Ouyang M; Galante H; Scaglione KM; Todi SV
Nat Commun; 2014 Aug; 5():4638. PubMed ID: 25144244
[TBL] [Abstract][Full Text] [Related]
24. Structural transformation of the tandem ubiquitin-interacting motifs in ataxin-3 and their cooperative interactions with ubiquitin chains.
Song AX; Zhou CJ; Peng Y; Gao XC; Zhou ZR; Fu QS; Hong J; Lin DH; Hu HY
PLoS One; 2010 Oct; 5(10):e13202. PubMed ID: 20949063
[TBL] [Abstract][Full Text] [Related]
25. FAT10 protein binds to polyglutamine proteins and modulates their solubility.
Nagashima Y; Kowa H; Tsuji S; Iwata A
J Biol Chem; 2011 Aug; 286(34):29594-600. PubMed ID: 21757738
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates.
Donaldson KM; Li W; Ching KA; Batalov S; Tsai CC; Joazeiro CA
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8892-7. PubMed ID: 12857950
[TBL] [Abstract][Full Text] [Related]
27. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
[TBL] [Abstract][Full Text] [Related]
28. Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates.
Zhong X; Pittman RN
Hum Mol Genet; 2006 Aug; 15(16):2409-20. PubMed ID: 16822850
[TBL] [Abstract][Full Text] [Related]
29. Nucleocytoplasmic shuttling activity of ataxin-3.
Macedo-Ribeiro S; Cortes L; Maciel P; Carvalho AL
PLoS One; 2009 Jun; 4(6):e5834. PubMed ID: 19503814
[TBL] [Abstract][Full Text] [Related]
30. Proteasome function is inhibited by polyglutamine-expanded ataxin-1, the SCA1 gene product.
Park Y; Hong S; Kim SJ; Kang S
Mol Cells; 2005 Feb; 19(1):23-30. PubMed ID: 15750336
[TBL] [Abstract][Full Text] [Related]
31. CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation.
Al-Ramahi I; Lam YC; Chen HK; de Gouyon B; Zhang M; PĂ©rez AM; Branco J; de Haro M; Patterson C; Zoghbi HY; Botas J
J Biol Chem; 2006 Sep; 281(36):26714-24. PubMed ID: 16831871
[TBL] [Abstract][Full Text] [Related]
32. Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: implication in a loss-of-function pathology.
Yang H; Li JJ; Liu S; Zhao J; Jiang YJ; Song AX; Hu HY
Sci Rep; 2014 Sep; 4():6410. PubMed ID: 25231079
[TBL] [Abstract][Full Text] [Related]
33. PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins.
Janer A; Martin E; Muriel MP; Latouche M; Fujigasaki H; Ruberg M; Brice A; Trottier Y; Sittler A
J Cell Biol; 2006 Jul; 174(1):65-76. PubMed ID: 16818720
[TBL] [Abstract][Full Text] [Related]
34. [Involvement of ubiquitin-proteasome system in polyglutamine disease].
Matsumoto M
Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1428-32. PubMed ID: 16922413
[No Abstract] [Full Text] [Related]
35. Ubiquitin-interacting motifs confer full catalytic activity, but not ubiquitin chain substrate specificity, to deubiquitinating enzyme USP37.
Tanno H; Shigematsu T; Nishikawa S; Hayakawa A; Denda K; Tanaka T; Komada M
J Biol Chem; 2014 Jan; 289(4):2415-23. PubMed ID: 24324262
[TBL] [Abstract][Full Text] [Related]
36. Molecular clearance of ataxin-3 is regulated by a mammalian E4.
Matsumoto M; Yada M; Hatakeyama S; Ishimoto H; Tanimura T; Tsuji S; Kakizuka A; Kitagawa M; Nakayama KI
EMBO J; 2004 Feb; 23(3):659-69. PubMed ID: 14749733
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3.
Todi SV; Winborn BJ; Scaglione KM; Blount JR; Travis SM; Paulson HL
EMBO J; 2009 Feb; 28(4):372-82. PubMed ID: 19153604
[TBL] [Abstract][Full Text] [Related]
38. Evidence for distinct functions for human DNA repair factors hHR23A and hHR23B.
Chen L; Madura K
FEBS Lett; 2006 Jun; 580(14):3401-8. PubMed ID: 16712842
[TBL] [Abstract][Full Text] [Related]
39. Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3.
Sutton JR; Blount JR; Libohova K; Tsou WL; Joshi GS; Paulson HL; Costa MDC; Scaglione KM; Todi SV
Hum Mol Genet; 2017 Apr; 26(8):1419-1431. PubMed ID: 28158474
[TBL] [Abstract][Full Text] [Related]
40. Orchestra for assembly and fate of polyubiquitin chains.
Kuhlbrodt K; Mouysset J; Hoppe T
Essays Biochem; 2005; 41():1-14. PubMed ID: 16250894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]